# A Feasibility Study on Ultrafiltration and Blood Volume Measurements

> **NCT04241718** · NA · TERMINATED · sponsor: **Nuwellis, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Acute Decompensated Heart Failure
- Fluid Overload

## Interventions

- **DEVICE:** Aquadex FlexFlow System and BVA-100

## Key facts

- **NCT ID:** NCT04241718
- **Lead sponsor:** Nuwellis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-19
- **Primary completion:** 2022-12-27
- **Final completion:** 2022-12-27
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04241718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04241718, "A Feasibility Study on Ultrafiltration and Blood Volume Measurements". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04241718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*